GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (CHIX:VIRPp) » Definitions » Buildings And Improvements

Virbac (CHIX:VIRPP) Buildings And Improvements : €367 Mil (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Virbac Buildings And Improvements?

Virbac's quarterly buildings and improvements increased from Dec. 2023 (€261 Mil) to Jun. 2024 (€369 Mil) but then declined from Jun. 2024 (€369 Mil) to Dec. 2024 (€367 Mil).

Virbac's annual buildings and improvements increased from Dec. 2022 (€247 Mil) to Dec. 2023 (€261 Mil) and increased from Dec. 2023 (€261 Mil) to Dec. 2024 (€367 Mil).


Virbac Buildings And Improvements Historical Data

The historical data trend for Virbac's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Buildings And Improvements Chart

Virbac Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 218.92 227.57 246.67 260.99 367.30

Virbac Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 246.67 253.53 260.99 369.16 367.30

Virbac Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Virbac Business Description

Traded in Other Exchanges
Address
13e rue LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.

Virbac Headlines

No Headlines